Home > News > Altair Nanotechnologies Licenses RenaZorb(TM)
January 31st, 2005
Altair Nanotechnologies Licenses RenaZorb(TM)
Abstract:
Altair Nanotechnologies announced today that a licensing agreement has been signed with California-based Spectrum Pharmaceuticals, giving Spectrum the exclusive worldwide rights for human therapeutic and diagnostic applications to develop, market and sell its RenaZorb™ product line. Altair's RenaZorb™ products, which target an emerging billion-dollar-plus market, are for phosphate control in patients with Chronic Kidney Disease (CKD) and hyperphosphatemia, high phosphate levels in blood, associated with End Stage Renal Disease (ESRD). These products are non-aluminum-, non-calcium-based phosphate binders, which utilize Altair's proprietary lanthanum nanomaterial technology.
Source:
marketwire
Bookmark:
| Related Links |
| Related News Press |
Nanomedicine
New metamaterial-enhanced MRI technique tested on humans May 26th, 2017
Controlling 3-D behavior of biological cells using laser holographic techniques May 26th, 2017
Zap! Graphene is bad news for bacteria: Rice, Ben-Gurion universities show laser-induced graphene kills bacteria, resists biofouling May 22nd, 2017
Sensors detect disease markers in breath May 19th, 2017
Announcements
Ag/ZnO-Nanorods Schottky diodes based UV-PDs are fabricated and tested May 26th, 2017
New metamaterial-enhanced MRI technique tested on humans May 26th, 2017
Controlling 3-D behavior of biological cells using laser holographic techniques May 26th, 2017
Unveiling the quantum necklace: Researchers simulate quantum necklace-like structures in superfluids May 26th, 2017
Patents/IP/Tech Transfer/Licensing
NREL’s Advanced Atomic Layer Deposition Enables Lithium-Ion Battery Technology: May 10th, 2017
Forge Nano 2017: 1st Quarter Media Update April 20th, 2017
'Neuron-reading' nanowires could accelerate development of drugs for neurological diseases April 12th, 2017
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
University Technology Transfer & Patents
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||